Interestingly, plasma GFAP values were not significantly different between ALS A+T− and A+T+, further indicating that astrogliosis, so GFAP elevation in blood, is an initial event in the AD pathogenetic cascade, as already supported by biomarkers studies in autosomal dominant AD mutation carriers [26]. The gene discussed is GFAP; the disease is amyotrophic lateral sclerosis.